Here's the opinion. The Drug & Device Law Blog has some analysis. I posted about the case extensively and wrote an article addressing issues of document leaks for The Review of Litigation as well.

As readers may recall, David Egilman was a plaintiffs' expert in the Zyprexa litigation and the courts concluded that he worked with Alaska attorney James Gottstein to make public documents designated as confidential under a protective order. Dr. Egilman settled the potential contempt litigation with a donation to a charity and with an affidavit in which he acknowledged, under oath, violating the protective order, releasing documents selectively, and so on. (The affidavit is here.)

TrackBack URL for this entry:$MTTrans>

Comments

Zyprexa legacy

The Lilly Zyprexa settlement saga is still ongoing and in default as some patient victim claimants like myself have not been payed.
The use of powerful antipsychotic drugs has increased in children as young as three years old. Weight gain, increases in triglyceride levels and associated risks for diabetes and cardiovascular disease.
The average weight gain (adults) over the 12 week study period was the highest for Zyprexa—17 pounds. You’d be hard pressed to gain that kind of weight sport-eating your way through the holidays

While psychiatrists are being paid by pharmaceutical companies to promote psychiatric drugs, people who are taking the drugs are dying. One in 145 adults died in clinical trials of those taking the antipsychotic drugs Zyprexa.
I took Zyprexa for 4 years got diabetes classic case